Lower in-hospital mortality for vaccinated patients hospitalized with COVID-19
COVID-19 patients in Kaiser Permanente Northern California hospitals during the delta surge of 2021 were less likely to die in the hospital of COVID-19 if they were vaccinated, new research finds.
COVID-19 pandemic brings telehealth center stage for oncologists and their patients
A new Kaiser Permanente research paper explains how Kaiser Permanente Northern California quickly ramped up its existing telehealth oncology program at the onset of the COVID-19 pandemic.
Kaiser Permanente joins late-stage COVID-19 vaccine study
The Division of Research has joined a phase 3 clinical trial testing a Pfizer/BioNTech vaccine against the COVID-19 virus. Kaiser Permanente Southern California and Northwest join them in this global effort.
Early data on COVID-19 vaccine in teens shows booster effectiveness
An analysis of early data on the effectiveness of the Pfizer/BioNTech COVID-19 vaccine in children and teens found that a third shot, or booster, extended protection against emergency department and urgent care visits in 16- and 17-year-olds.
COVID-19 vaccination not tied to postmenopausal bleeding
Kaiser Permanente study does not support anecdotal reports that postmenopausal bleeding was common after COVID-19 vaccination.
